Cowen lowers Tilray's price target but maintains its 'outperform' rating.
Canopy Growth's fiscal second-quarter revenue misses analysts' estimates.
Tilray shares are falling after reporting mixed third-quarter results.
Cronos sells 213% more cannabis by kilograms in the third quarter than it did a year ago.
With Tilray set to report earnings after today's closing bell, we're rewinding to our sit-down with CEO Brendan Kennedy.
Aurora Cannabis reports fiscal first-quarter revenue growth of 260%.
IGC and Tilray rise by double-digit percentages and other weed stocks rally as anti-pot attorney general steps down and voters back cannabis sales in three states.
Michigan becomes the 10th U.S. state to legalize the recreational use of marijuana.
CV Sciences CEO discusses the medical applications of CBD at Jim Cramer's teach in.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.